2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Outcome – High Priority Description Percentage of patients undergoing pelvic organ prolapse repairs whoContinue reading “2024 MIPS Measure #432: Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair”
MIPS/CQM Archive
2024 MIPS Measure #433: Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Outcome – High Priority Description Percentage of patients undergoing surgical repair of pelvic organContinue reading “2024 MIPS Measure #433: Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair”
2024 MIPS Measure #436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of final reports for patients aged 18 years and older undergoingContinue reading “2024 MIPS Measure #436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques”
2024 MIPS Measure #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of the following patients – all considered at high risk ofContinue reading “2024 MIPS Measure #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease”
2024 MIPS Measure #439: Age Appropriate Screening Colonoscopy
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Efficiency – High Priority Description The percentage of screening colonoscopies performed in patients greaterContinue reading “2024 MIPS Measure #439: Age Appropriate Screening Colonoscopy”
2024 MIPS Measure #440: Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of biopsies with a diagnosis of cutaneous basalContinue reading “2024 MIPS Measure #440: Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician”
2024 MIPS Measure #441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) Measure Type Intermediate Outcome – High Priority Description The IVD All-or-None Measure is one outcome measureContinue reading “2024 MIPS Measure #441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)”
2024 MIPS Measure #443: Non-Recommended Cervical Cancer Screening in Adolescent Females
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description The percentage of adolescent females 16–20 years of ageContinue reading “2024 MIPS Measure #443: Non-Recommended Cervical Cancer Screening in Adolescent Females”
2024 MIPS Measure #445: Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Outcome – High Priority Description Percent of patients aged 18 years and older undergoingContinue reading “2024 MIPS Measure #445: Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)”
2024 MIPS Measure #448: Appropriate Workup Prior to Endometrial Ablation
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of patients, aged 18 years and older, whoContinue reading “2024 MIPS Measure #448: Appropriate Workup Prior to Endometrial Ablation”